Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
Equities
603707
CNE100002WP3
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.53 CNY | -1.57% | -6.42% | -16.47% |
05-28 | Hybio Pharmaceutical Gets Nod to Market Ganirelix Acetate Injection | MT |
05-13 | NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.47% | 2.79B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 603707 Stock
- News Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
- NKFPharma's Unit Gets FDA's Nod to Market Eptifibatide Injection in US